The global central nervous system (CNS) therapeutics market size reached US$ 140.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 239.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032. The growing prevalence of neurological and psychiatric disorders among the masses, the rise in telehealth and telemedicine services, and the incr... https://www.imarcgroup.com/central-nervous-system-therapeutics-market